[go: up one dir, main page]

ES2092685T3 - Uso de atipamezol para el tratamiento de impotencia sexual masculina. - Google Patents

Uso de atipamezol para el tratamiento de impotencia sexual masculina.

Info

Publication number
ES2092685T3
ES2092685T3 ES92911915T ES92911915T ES2092685T3 ES 2092685 T3 ES2092685 T3 ES 2092685T3 ES 92911915 T ES92911915 T ES 92911915T ES 92911915 T ES92911915 T ES 92911915T ES 2092685 T3 ES2092685 T3 ES 2092685T3
Authority
ES
Spain
Prior art keywords
treatment
atipamezol
male sexual
sexual impotence
impotence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911915T
Other languages
English (en)
Inventor
Antti Pertovaara
Ilkka Linnankoski
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of ES2092685T3 publication Critical patent/ES2092685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE LA ATIPAMEZOLA A UNA SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE DE LA MISMA PARA EL TRATAMIENTO DE LA IMPOTENCIA SEXUAL MASCULINA.
ES92911915T 1991-06-18 1992-06-18 Uso de atipamezol para el tratamiento de impotencia sexual masculina. Expired - Lifetime ES2092685T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113077A GB9113077D0 (en) 1991-06-18 1991-06-18 Use of atipamezole

Publications (1)

Publication Number Publication Date
ES2092685T3 true ES2092685T3 (es) 1996-12-01

Family

ID=10696833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911915T Expired - Lifetime ES2092685T3 (es) 1991-06-18 1992-06-18 Uso de atipamezol para el tratamiento de impotencia sexual masculina.

Country Status (21)

Country Link
EP (1) EP0589957B1 (es)
JP (1) JP3151217B2 (es)
KR (1) KR100324447B1 (es)
AT (1) ATE144141T1 (es)
AU (1) AU661698B2 (es)
CA (1) CA2102187C (es)
CZ (1) CZ284409B6 (es)
DE (1) DE69214647T2 (es)
DK (1) DK0589957T3 (es)
ES (1) ES2092685T3 (es)
GB (1) GB9113077D0 (es)
GR (1) GR3021677T3 (es)
HU (1) HU220068B (es)
IE (1) IE921735A1 (es)
IL (1) IL101961A (es)
MX (1) MX9202948A (es)
NO (1) NO304011B1 (es)
NZ (1) NZ242863A (es)
RU (1) RU2111749C1 (es)
WO (1) WO1992022296A1 (es)
ZA (1) ZA923961B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2180591C2 (ru) * 1999-12-24 2002-03-20 Государственное научное предприятие Московский научно-исследовательский институт психиатрии МЗ РФ Средство для лечения сексуальных дисфункций у мужчин
FI20000073A0 (fi) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Uusia imidatsolijohdannaisia
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä

Also Published As

Publication number Publication date
DK0589957T3 (da) 1996-11-18
HUT65817A (en) 1994-07-28
NO934690D0 (no) 1993-12-17
EP0589957A1 (en) 1994-04-06
CZ248793A3 (en) 1994-04-13
NO304011B1 (no) 1998-10-12
GB9113077D0 (en) 1991-08-07
WO1992022296A1 (en) 1992-12-23
JPH06508350A (ja) 1994-09-22
ATE144141T1 (de) 1996-11-15
RU2111749C1 (ru) 1998-05-27
IL101961A (en) 1995-12-31
MX9202948A (es) 1993-04-01
AU1972492A (en) 1993-01-12
IE921735A1 (en) 1992-12-30
JP3151217B2 (ja) 2001-04-03
CZ284409B6 (cs) 1998-11-11
CA2102187C (en) 2003-03-11
IL101961A0 (en) 1992-12-30
AU661698B2 (en) 1995-08-03
EP0589957B1 (en) 1996-10-16
HU220068B (hu) 2001-10-28
ZA923961B (en) 1993-02-24
DE69214647D1 (de) 1996-11-21
KR100324447B1 (ko) 2002-06-20
NO934690L (no) 1993-12-17
DE69214647T2 (de) 1997-02-20
NZ242863A (en) 1997-06-24
GR3021677T3 (en) 1997-02-28
CA2102187A1 (en) 1992-12-19

Similar Documents

Publication Publication Date Title
CY1106239T1 (el) ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΔΙΑΜΟΡΦΩΣΕΙΣ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΕΛΕΥΘΕΡΩΣΗΣ ΠΟΥ ΠEPΙΕΧΟΥΝ ΑΝΑΣΤΟΛΕΑ cGMP PDE-5
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
PA8476301A1 (es) Formulaciones intranasales para tratar trastornos sexuales
CA2043033A1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
ES520914A0 (es) Procedimiento para el tratamiento de lodos industriales residuales.
ES2092685T3 (es) Uso de atipamezol para el tratamiento de impotencia sexual masculina.
AR244073A1 (es) Dispositivo para el tratamiento de la disfuncion sexual masculina.
ES2089194T3 (es) Nuevo uso de linomide.
RU93058537A (ru) Применение атипамезола для лечения мужской сексуальной импотенции
MX9204286A (es) Agentes para el tratamiento de semillas.
ES2158647T3 (es) Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal.
ES1031636Y (es) Aparato para el aprovechamiento de aguas domesticas utilizadas.
FI890173L (fi) Isoxazoler med nootropisk verkan.
ES1011920Y (es) Dispositivo para el tratamiento de los genitales masculinos.
ES1030216Y (es) Cinturon terapeutico para el tratamiento de la impotencia.
ES1009822Y (es) Dispositivo para el tratamiento de la impotencia sexual de hombres.
PT967986E (pt) Utilizacao de glicoproteina alfa1-acida para a preparacao de um preparado farmaceutico
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
ES1023421Y (es) Expansor patra el relleno de bolsas o similares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589957

Country of ref document: ES